Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer

Protgen

Status: Unknown

Conditions: Liver Cancer

Treatments: Device: hsp90

Study type: Interventional

Funder types: Industry

Identifiers

NCT02324127

hsp90a2011-05

Details and patient eligibility

About

Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.

Full description

Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases, validate accuracy, specificity and sensitivity of Hsp90α kit.

Enrollment: 1,100 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Liver cancer patients
• Healthy volunteers,
• Benign liver diseases patients

Exclusion criteria

• Patients who Previously accepted radiotherapy

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,100 participants in 1 patient group

liver cancer

Experimental group

Description:

Detect plasma Hsp90α concentration of liver cancer patients

Treatment:

Device: hsp90